Monday, August 31, 2026

Peloton Stock Takes A Nosedive: Down 23% In 10 Sessions

ViaNews Editorial Team

February 8, 2024

Peloton Stock Takes A Nosedive: Down 23% In 10 Sessions

(VIANEWS) - Peloton (NASDAQ: PTON) shares have experienced a dramatic decline over the last 10 sessions, dropping 23.58% from EUR5.86 on January 30th to EUR4.448 at 10:49 EST on Thursday despite overall market increases of 0.13% to EUR15,776.44. This performance decline means Peloton's last closing price at EUR4.39 represents an 85.71% decrease from its 52-week high of EUR17.83.

About Peloton

Peloton Interactive, Inc. is a premier provider of connected fitness products, featuring touchscreen-enabled bikes, treadmills, and rowing machines with access to live and on-demand fitness classes. Their flagship products - Peloton Bike+, Tread, and Tread+ are popular choices among fitness enthusiasts around the globe. Established in 2012 and headquartered in New York, NY respectively; onepeloton.com serves consumers directly.

Yearly Analysis

Peloton's current stock value of EUR4.48 is substantially less than its 52-week high of EUR17.83 but significantly greater than its 52-week low of EUR4.28; this indicates a decline in value over the past year. Peloton anticipates sales growth of negative 1.9% this year, which suggests the company may not be performing as anticipated. Next year's sales growth estimate stands at 5.3%. Peloton currently boasts an EBITDA of -33.36, signalling to investors that it is not producing positive earnings and incurring significant expenses. Such a negative EBITDA reading should cause concern as this could indicate financial issues for Peloton.

Technical Analysis

Peloton stock has struggled to hold onto its value recently, falling well below both its 50-day and 200-day moving averages of EUR5.87 and EUR6.76, respectively. Volume has also seen a substantial decrease from its average volume of 14626000 with reported volume now standing at 3553179 which represents a 77.03% decrease. Volatility has fluctuated across recent weeks ranging from last week's intraday variation average being negative 0.32% through to last month's negative 3.97% and quarter's positive 5.27% amplitude being 5.15% (last week), 5.98% (last month), and quarter's positive 5.27% (last quarter). As far as stock price classification goes, Peloton's stock currently falls into an oversold condition (=20). Investors should take notice and assess if its current price represents an opportunity to buy or an impending further decline.

Quarter Analysis

According to available information, the company estimates its growth for this quarter at 45.9% and 57% for next quarter respectively; year-on-year quarterly revenue growth has slowed by 3.4% with 2.78B generated within 12 months. As an AI language model, I cannot provide investment advice or recommendations; however, I suggest that investors consider the company's estimated growth estimates, revenue growth rates, overall financial performance as well as industry trends and macroeconomic factors that might have an effect on its growth prospects when making investment decisions. Conducting extensive research or consulting with an investment expert or advisor could assist them in making well-informed choices when making investment decisions.

Equity Analysis

Earnings per Share (EPS) is a financial metric used to gauge a company's profitability per outstanding share. A negative EPS value indicates losses over the previous twelve months. Peloton has recorded trailing twelve months earnings per share (EPS) of EUR-2.44 for its previous twelve month period, indicating losses during that time. However, EPS should not be used as the sole measure of financial performance; other financial metrics, including revenue, gross margin and operating expenses must also be taken into consideration to gain a full understanding of a company's health.

More news about Peloton (PTON).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI's Trust Gap: Microsoft-Mistral Ecosystem Expansion Meets a Governance Deficit in Agentic Adoption
Microsoft is deepening its AI platform bet through simultaneous moves — expanding its Mistral partnership (Copilot Studio, Foundry, European infrastructure capacity) and deepening enterprise AI governance ties with Manulife — just as independent research (Google Cloud, VentureBeat, Box) shows enterprises racing toward agentic AI adoption (100% planned within two years) while data access and trust in agent decisions lag badly (average 45% data access, only ~half trust agent outputs). The result is a structural mismatch between platform-vendor momentum and enterprise readiness to actually govern and trust the agents being deployed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
Same entity (Morgan Stanley & Co. LLC), same metric (net_income), same fiscal period (Q1 2026), same observation date (2026-03-31), but vastly different values: $5.567 billion vs. $5.57. These cannot coexist for the same time period. Fact B appears to be a data entry error (possible missing decimal placement: 5.57 should likely be 5,567,000,000 or a per-share figure incorrectly entered as total).
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,257 source documents archived
Query this data → isubstrate.com